COVID-19 HIV CO-INFECTION

DATA DASHBOARD

In March the NEAT ID Foundation initiated the development of a simple Data “Dashboard” to monitor the progress of COVID-19 in HIV infected patients across Europe in real time. The Dashboard shows at European and Country level the number of cases reported to NEAT ID with COVID-19 co-infection with HIV, the number of hospitalisations and the number of deaths (from sites who have contributed to date).

​

​

The Public area of the dashboard is now open to view by clicking the link.

​

​

​

​

It is still open for Clinical Sites to Register and upload data (Individual clinic data will only be seen by the submitting site and will be password and security protected) - please click the Register button.

​

​

​

​

If you have already registered you can now upload Your data by using the Enter Data button –

(you will still need your login and password).

​

​

​

​

COVID-19 HEPATITIS CO-INFECTION DATA DASHBOARD

In May, as a response to interest in Covid-19 Co-infection in Hepatitis patients we have introduced a further Data Dashboard.  If you are a Clinical Site who would like to take part in this initiative, please click the REGISTER button and follow the registration process to receive a login and password.

​

​

​

 

If you have registered, you can now upload your data by using the ENTER DATA button below. You will still require your login and password

 

 

​

 

 

The European Association for the Study of the Liver (EASL) is also supporting an initiative – to find out more please click this button

​

Virus no background.png

The European treatment network of HIV, hepatitis and global infectious diseases

Mission

​

NEAT ID's mission is to perform and coordinate Clinical Research on HIV/AIDS and associated Infectious Diseases at European and International levels. 

​

​

Objectives

​​

  • Develop new strategies and approaches to the treatment of HIV and associated Infectious Diseases

  • Promote networking of trans-national research, from proof of principle to phase III – IV clinical trials

  • Integrate leading HIV/AIDS Research Institutions and Clinical Centres through a coherent, multi-disciplinary and durable research programme

  • Optimise resources and infrastructures, disseminate technology and spread expertise and resources

  • Provide training and mobility of scientists and foster lasting collaborations in Europe and Internationally